Industry practice
Compress discovery from years to weeks — inside the guardrails
AI now sits at the centre of the discovery pipeline: protein-structure and interaction models let teams reason about targets in hours, generative models propose candidate molecules and antibodies, ML-optimised CRISPR guides cut off-target edits, and self-driving labs run thousands of experiments a day. We train discovery-stage biotech, genomics and synthetic-bio teams to use these systems rigorously — with validation discipline and a regulatory-ready posture.
- 0%
- literature/discovery time saved
- 0×
- experiment throughput in labs
- 0+
- biotech teams trained
What we deliver
Engineered for measured outcomes
AI-accelerated drug discovery, genomics and synthetic biology.

- Protein-structure and interaction models in target work
- Generative molecule and antibody design with validation gates
- ML-based CRISPR guide optimisation and off-target analysis
- Self-driving-lab closed-loop experiment design
- Evidence documentation for publication and regulators
Start here
Programs teams pair with biotech & genomics
Start today
Bring biotech & genomics excellence to your organisation
One working session with our principals turns this page into your programme plan.